MRSAid is a novel non-antibiotic therapy developed for use in hospital/long-term care settings for nasal decolonization of potentially pathogenic bacteria, including MRSA. Developed by Ondine Biomedical Inc., the global leaders in antimicrobial photodynam

MRSAid is a novel non-antibiotic therapy developed for use in hospital/long-term care settings for nasal decolonization of potentially pathogenic bacteria, including MRSA. Developed by Ondine Biomedical Inc., the global leaders in antimicrobial photodynam

MRSAid is a novel non-antibiotic therapy developed for use in hospital/long-term care settings for nasal decolonization of potentially pathogenic bacteria, including MRSA. Developed by Ondine Biomedical Inc.

Ondine Biomedical Inc. is dedicated to the development of non-antibiotic, anti-infective therapies for a broad spectrum of bacterial, viral and fungal infections.